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Abstract
Background: The sheep is an important model animal for testing novel fracture treatments and
other medical applications. Despite these medical uses and the well known economic and cultural
importance of the sheep, relatively little research has been performed into sheep genetics, and
DNA sequences are available for only a small number of sheep genes.
Results: In this work we have sequenced over 47 thousand expressed sequence tags (ESTs) from
libraries developed from healing bone in a sheep model of fracture healing. These ESTs were
clustered with the previously available 10 thousand sheep ESTs to a total of 19087 contigs with an
average length of 603 nucleotides. We used the newly identified sequences to develop RT-PCR
assays for 78 sheep genes and measured differential expression during the course of fracture
healing between days 7 and 42 postfracture. All genes showed significant shifts at one or more time
points. 23 of the genes were differentially expressed between postfracture days 7 and 10, which
could reflect an important role for these genes for the initiation of osteogenesis.
Conclusion: The sequences we have identified in this work are a valuable resource for future
studies on musculoskeletal healing and regeneration using sheep and represent an important head-
start for genomic sequencing projects for Ovis aries, with partial or complete sequences being made
available for over 5,800 previously unsequenced sheep genes.
Published: 05 July 2006
BMC Genomics 2006, 7:172 doi:10.1186/1471-2164-7-172
Received: 08 March 2006
Accepted: 05 July 2006
This article is available from: http://www.biomedcentral.com/1471-2164/7/172
© 2006 Hecht et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
Page 2 of 20
(page number not for citation purposes)
Background
The accumulation of genome-wide sequence data for
model organisms is of obvious benefit for many kinds of
scientific analysis. Although the sheep is of great eco-
nomic importance and has been used as a model organ-
ism to study such diverse topics as fracture healing [1],
ovarian function [2], hypernatremic hypertension [3],
and pulmonary function [4], relatively little sequence
information is available for this organism, and DNA
sequences are available for only a small number of sheep
genes.
2030 loci, 543 of which are designated as genes, are cur-
rently listed in the ArkDB sheep database [5]. In UniGene
[6] Build 7 for Ovis aries, a total of 5,730 EST and mRNA
sequences form a total of 1714 clusters, and the EBML
database [7] currently contains 10497 ESTs and 2391
mRNA entries for sheep.
Fractures, and especially osteoporotic fractures in the eld-
erly, represent a major public health problem. As popula-
tions age, the costs of treating osteoporotic fractures,
currently billions of dollars a year in the United States
alone, are predicted to dramatically increase [8]. Conse-
quently, a better understanding of the genetic processes
underlying fracture healing is of great medical relevance.
The process of fracture healing is a regenerative process
that in many ways is similar to bone development. The
fracture repair process goes through many stages, begin-
ning with an inflammatory response and the recruitment
and proliferation of undifferentiated mesenchymal cells.
Mesenchymal cells from the periosteum near the fracture
site differentiate into osteoblasts and induce intramem-
branous ossification resulting in the formation of new
bone. Simultaneously, cartilage is formed at the fracture
site and undergoes enchondral ossification. The newly
produced bone then undergoes extensive remodeling
until the original shape and structure of the bone is
restored. Many of the molecular signals and processes
involved in fracture healing closely resemble those
involved in bone development [9-11].
In the present work, we have extracted 47 thousand ESTs
from libraries developed from healing bone in a sheep
model of fracture healing. We clustered our sequences
together with previously identified ESTs, and identified
19087 contigs, the majority of which represented previ-
ously unsequenced sheep genes. These newly identified
sequences were used to perform RT-PCR on 78 genes from
the postfracture day 7, 10, 14, and 42 libraries. We con-
firmed differential expression for genes previously known
to be involved in fracture healing and demonstrated dif-
ferential expression for numerous genes not previously
known to be involved in fracture healing.
Results
ESTs and assembly into contigs and creation of an Ovis 
aries sequence database
In addition to the 47209 sheep ESTs generated from three
libraries in the current project (Table 1), we extracted
10497 ESTs and 2391 mRNA entries from the EMBL data-
base (release 82, Sept 2005). 344 sequences were rejected
because less than 40 bp remained unmasked following
quality control procedures. The lengths of the ESTs ranged
from 40 to 928 with an average length of 555 nucleotides
(Fig. 1a). All bases beyond 750 bp were masked. Using
our sequences as well as the previously available
sequences, 19087 contigs were assembled with an average
length of 603 nucleotides (Fig. 1b). 397 contigs were
shorter than 100 nucleotides and were excluded from fur-
ther analysis. On average, each contig was assembled from
3.1 ESTs from all libraries, with a range of 0 to 2392 ESTs
per contig (some contigs consisted only of previously
available mRNA data and contained no ESTs). If the anal-
ysis is restricted to ESTs from the libraries described in this
work, then each contig contained an average of 2.5 ESTs
(Range: 0 – 2387). The contigs comprised of the largest
number of ESTs were identified as collagen Iα1 (2387
ESTs), collagen Iα2 (1094 ESTs), and osteonectin (1086
ESTs). A total of 8965 contigs contained only a single EST
clone.
We used the GeneNest package [12,13] to analyze all
available mRNA and EST sequences and to present the
sequences in a user-friendly internet site. The main fea-
tures of the GeneNest Sheep database are summarized in
Fig. 2.
BLAST analysis of Ovis aries contigs to assign putative 
gene identities based on homology
BLAST searches were used to attempt to assign putative
identities to the contig sequences identified in this study.
Analysis against the NCBI RefSeq protein sequence data-
base was performed, and 13149 contigs demonstrated a
best e-value of 0.01 or lower (Fig. 3a). We used an arbi-
trary e-value cutoff of 10-25 to identify significant homol-
ogy to a known gene and allow a probable assignment of
a sheep contig. With this cutoff, a total of 10387 contigs
demonstrated significant homology to at least one other
protein in the RefSeq protein database and could be
assigned a putative identity, consisting of a total of 8789
distinct proteins. In cases where hits to a proteins from
Table 1: EST counts of the libraries.
Library ESTs Number of contigs
PF7 14884 5859
PF10 17148 6217
Pooled 15177 5421BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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Distribution of sequence length and EST count per contig Figure 1
Distribution of sequence length and EST count per contig. a) Distribution of the read length of the ESTs after quality 
control, b) Distribution of sequence length of the assembled contigs.
a) Distribution of EST Lengths
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several species were identified, the most significant match
was used to assign a putative identity. 292 contigs blasted
to an Ovis aries RefSeq. A total of 2863 contigs (15%) had
e-values of less than 10-100 and are thus likely to represent
true orthologs. Of the 19087 contigs, 11591 were assem-
bled from ESTs only from the current project. 6577 were
assigned to 5839 distinct RefSeq sequences by virtue of
blastx e-values of 10-25 or less. These sequences represent
previously unidentified sheep genes. The sequences for
these genes are available in FASTA format with the online
supplemental material as [Additional file 1]
Gene-Ontology analysis of the sheep fracture libraries
GO analysis was performed by assigning annotations to
the sheep contigs from the MGI annotations of putative
murine homologs (e-value threshold 10-25) in order to get
an overview of the subset of genes expressed in healing
fracture tissue of the sheep. Fig. 3b provides an overview
of the results of this BLAST analysis. Putative homologs
were found for 5637 distinct sheep genes, some of which
were defined from multiple contig sequences. MGI anno-
tations were available for 4600 of the 5637 genes. The
results of the GO analysis using these annotations are
summarized in Fig. 4. Many of the most frequently anno-
tated terms in the subontology biological process, such as
development, signal transduction, transcription, biosynthesis,
and phosphate metabolism, reflect processes known to be
involved in fracture healing and bone development. The
distribution of annotations to terms in the subontology
cellular component shows that the gene products corre-
GeneNest Ovis aries gene index database Figure 2
GeneNest Ovis aries gene index database. In this example, the data for integrin-binding sialoprotein (IBSP) are shown. A 
cluster based on three contigs, each of which can be individually displayed, corresponds to IBSP. EST sequences from which the 
contigs were constructed as well as their locations and libraries are displayed. A consensus sequence can be downloaded for 
each contig. Open-reading frames can be optionally displayed, and other options for data display are available [12]. The data-
base is publicly available at http://genenest.molgen.mpg.de/cgi-bin/search_db?db=Oa5.BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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Distribution of the e-values of different BLAST analyses Figure 3
Distribution of the e-values of different BLAST analyses. Distribution of e-values for Ovis aries contigs blasted against 
the RefSeq protein database (a) or the nonredundant mRNA database restricted to mouse sequences (b).
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GO analysis Figure 4
GO analysis. A histogram showing the counts of genes annotated to GO categories for Biological Process and Cellular Com-
ponent among the 4600 mapped sheep genes for which MGI annotations of putative mouse homologs were available. Terms 
were selected from among the most frequently annotated and terms deemed to be particularly interesting for fracture healing. 
a) Terms from the subontology biological process. b) Terms from the subontology cellular component.
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sponding to the ESTs identified in this work are active in
many different cellular and extracellular locations.
A comparison of the sheep fracture libraries with normal 
human bone libraries
During development and in related processes such as frac-
ture healing, genes exhibit complex patterns of spatial and
temporal regulation. The identification of genes that are
differentially expressed during fracture healing therefore
represents an important initial investigation to discover
genes that are essential for fracture healing.
In this work, we generated two EST libraries from early
fracture healing stages (PF7 and PF10) with the goal of
identifying genes important in the earliest stages of frac-
ture healing. Following fracture, initial hemorrhage into
the fractured bone is followed by hemostasis and a phase
of inflammation, which lasts up to two weeks in the sheep
(Fig 5). Intramembranous ossification begins around day
10. Therefore, we reasoned that genes that are overex-
pressed in the PF7 and PF10 libraries could represent
genes with potential importance for the initiation of new
bone formation. To estimate gene expression levels in the
two libraries, we compared EST sequence counts using a
two-tailed Fisher exact test. This analysis revealed statisti-
cally significant differential expression for only three
genes; tartrate resistant acid phosphatase 5 (ACP5)
increased by a fold change of 10.60 (5 to 53 ESTs), cyto-
chrome c oxidase subunit I (COX1) increased by a fold
change of 2.1 (87 to 178 ESTs), and perlecan decreased by
a fold change of 3.9 (31 to 8 ESTs). We did not perform
such a comparison using the third EST library, because the
latter was derived from a mix of time points using PCR
amplification of cDNA inserts in order to get a broader
overview of the genes involved in the many stages of frac-
ture healing in sheep.
RNA samples from intact sheep bone were not available.
Therefore, we chose to compare the EST distribution in
the PF7 and PF10 libraries to that of two resting human
bone EST libraries. We reasoned that genes that were sig-
nificantly more highly expressed in the sheep libraries
could represent candidate fracture-healing related genes
that might warrant closer investigation. A total of 39 genes
with Benjamini-Hochberg-corrected p-values less than an
arbitrary threshold of 0.05 were identified as putatively
Time course of fracture healing in Ovis aries Figure 5
Time course of fracture healing in Ovis aries. Time line showing the central processes during fracture healing in a sheep 
model under standardized external fixation (mechanically uncritical). The starting time and duration of each process were esti-
mated from histological analysis at the indicated time points. The temporal extension of the enchondral ossification phase is 
loosely defined with the starting and ending point probably being localized between the analyzed time points (Lienau, Schell, 
and Duda, unpublished data).
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inﬂammation
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differentially expressed. Table 2 gives details on the genes
and number of ESTs found (see Methods for abbrevia-
tions). Links to corresponding contigs in the GeneNest
database are given in [Additional file 2].
It is striking that 24 of the 39 genes (62%) had previously
been known to be involved with developmental processes
in some way (references are given in the table). Eleven of
the 24 genes were previously known to be involved in
Table 2: Significantly overexpressed genes in early fracture tissue. The columns Gene and UniGene show the symbol and UniGene 
cluster id for the human ortholog of the sheep gene in question. See Methods for abbreviations. The genes are ordered according to 
Benjamini-Hochberg (BH)-corrected p-value. EST Ratio shows the EST counts from PF7/PF10 vs. the counts in the resting human 
bone libraries; the adjusted count ratio is given in parentheses followed by the BH-corrected p-value. The adjusted count ratio was 
calculated by the formula ad/bc, where a was the count of a given gene in the PF7/PF10 libraries, b the total count of ESTs in PF7/PF10, 
c the count of the gene in the human EST libraries, and d the total count of ESTs in the human libraries. That is, the EST counts of 
individual genes were corrected for the total number of ESTs in the EST libraries to provide information about the relative abundance 
of ESTs corresponding to a given gene. RT-PCR summarizes the statistical analysis of the RT-PCR results for the comparison between 
PF7 and PF10 (first entry), among PF7, PF10, and PF14 (second entry), and among PF7, PF10, PF14, and PF42 (third entry). '-' 
indicates non-significant, '*' indicates an adjusted p-value of 0.05 > p > 10-4, and "**" indicates a p-value less than 10-4. "n.d.", not done. 
A complete list of absolute fold change values for all genes is available in the online supplement. Bone/Development indicates whether 
the gene in question has previously been shown to be involved in bone development or fracture healing (first entry) or development 
(second entry). See Methods for the abbreviations. §No values were available for the 14d time point for FTH1.
Gene Unigene EST Ratio RT-PCR Bone/Development
EEF1A1 Hs.522463 664:32 (4.3; p = 5.7 × 10-21) -/*/** +/+ [60]
COX1 Hs.550345 265:0 (-;p = 4.0 × 10-19) n.d. -/+ [61]
RPLPO Hs.448226 278:1 (57; p = 1.3 × 10-18) -/**/** -/-
COL1A1 Hs. 172928 1987:249(1.6; p = 5.3 × 10-13) */**/** +/+ [62]
Osteonectin Hs.111779 588:39(3.1; p = 2.9 × 10-12) -/*/** +/+ [63]
RPS2 Hs.506997 268:7 (7.9; p = 8.6 × 10-12) */**/** -/-
FTH1§ Hs.558804 332:14 (4.9; p = 3.7 × 10-11) -/-/** +/+ [60]
RPL3 Hs.119598 179:1 (37; p = 4.4 × 10-11) -/*/** -/+ [64]
LAMR1 Hs.558354 221:4 (11; p = 4.9 × 10-11) -/**/** +/+ [11]
UBC Hs.520348 190:3 (13; p = 8.5 × 10-10 */**/** -/-
ITM2C Hs.111577 114:0 (-;p = 1.4 × 10-7) -/**/** +/+ [42]
COL3A1 Hs.443625 444:42 (2.2; p = 1.8 × 10-5) -/**/** -/+ [65]
EEF2 Hs.515070 85:0(-;p = 2.9 × 10-5) -/**/** -/+ [66]
COL4A1 Hs.17441 105:2 (11; p = 9.5 × 10-5) -/*/* -/+ [67]
RPL7A Hs.558380 78:0(-;p = 9.6 × 10-5) -/*/** -/+ [68]
K- ALPHA- 1 Hs.334017 89:1 (18; p = 0.00016) */**/** -/-
ACTA1 Hs.1288 72:0 (-;p = 0.00021) */**/** -/-
SLC25A6 Hs.350927 71:0(-;p = 0.00032) -/**/** -/+ [69]
EIF4A1 Hs. 129673 82:1(17; p = 0.00047) n.d. -/-
HMOX1 Hs.517581 66:0 (-;p = 0.00066) */**/** -/+ [41]
FTL Hs.433670 63:0 (-; p = 0.00096) -/*/** -/+ [70]
RPL7 Hs.421257 63:0 (-; p = 0.00096) -/**/** -/-
ACP5 Hs.1211 58:0 (-;p = 0.0019) */**/** +/+ [71]
SERPINH1 Hs.241579 154:10 (3.2; p = 0.0038) */**/** +/+ [22]
GNAI2 Hs.77269 52:0 (-; p = 0.0072) -/**/* -/+ [72]
RPS5 Hs.378103 62:1 (18; p = 0.0080) n.d. -/-
EIF5A Hs.534314 73:2 (7.5; p = 0.0083) n.d. -/-
RPS3 Hs.546286 50:0 (-;p = 0.0089) -/**/** -/-
MMP14 Hs.2399 47:0 (-;p = 0.013) **/**/** +/+ [73]
APOE Hs.515465 47:0 (-; p = 0.013) -/-/* -/-
ENO1 Hs.517145 146:11 (2.7; p = 0.017) n.d. +/+ [60]
HLA-A Hs.181244 88:4 (4.5; p = 0.018) n.d. -/-
KARS Hs.3100 44:0 (-;p = 0.019) -/*/* -/-
Basigin Hs.501293 45:0 (-;p = 0.019) -/*/** -/+ [74]
CD74 Hs.436568 56:1 (11; p = 0.024) n.d. -/+ [75]
RPL10 Hs.401929 43:0 (-; p = 0.025) -/**/** +/+ [76]
PGK1 Hs.78771 54:1 (11; p = 0.026) n.d. -/-
FCGRT Hs.111903 40:0 (-;p = 0.031) -/*/** -/-
NSEP1 Hs.512451 50:1 (10; p = 0.036) n.d. -/+ [77]BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
Page 9 of 20
(page number not for citation purposes)
bone development or fracture healing. Given that fracture
healing is thought to recapitulate bone development on a
molecular level [9], these findings are suggestive that our
EST analysis captured some essential aspects of fracture
healing.
Expression analysis of candidate fracture-healing related 
genes
We then reasoned that differential expression during the
course of fracture healing could be another kind of indica-
tor for genes with potential importance in fracture heal-
ing. Therefore, we performed RT-PCR expression analysis
using samples from postfracture day 7, 10, 14, and 42. The
RNA source for days 7 and 10 was identical to that used
for the PF7 and PF10 EST libraries, and the source for day
14 was one of the RNA samples used to construct the
pooled EST library. The day 42 RNA sample was not used
for any of the EST libraries. Samples from normal sheep
bone were not available.
PCR primers were designed for 30 of the genes in Table 2
and for an additional 48 candidate genes (Table 3), that
were chosen for biological interest or because of tenden-
cies toward overexpression that did not reach statistical
significance.
Almost all genes showed a large drop in expression at the
42-day time point. Early stage callus tissue is a metaboli-
cally highly active tissue. In comparison, healthy bone is
less metabolically active, which is not surprising given
that cells make up only around 2% of the total mass of
bone. It has previously been noted that the expression of
many genes related to fracture healing drops to very low
or undetectable levels at 6 weeks after fracture in a rat
model [14]. In our experiments, 77 of the 78 genes (99%)
tested by ANOVA over all four timepoints were found to
be significantly differentially expressed, a proportion that
dropped to 96% if only the first three time points were
considered, and 31% for a comparison between only the
first two time points. [Additional file 2] presents the nor-
malized expression values determined in these experi-
ments.
We then performed hierarchical clustering to produce a
graphic representation of the the expression patterns for
the genes investigated in RT-PCR. We used the gap-stat
method [15] to estimate the number of clusters in the data
(Fig. 6). The estimated number of clusters is two. How-
ever, the gap function rises again with peaks at 4 and 6
clusters, suggesting that there are less well defined groups
of four and of six clusters in the data. For the purposes of
discussion and visualization, we chose to partition the
genes into six clusters (Fig. 7). Clusters A, B, E and F dem-
onstrated high frequencies of genes of specific functional
classes (see below).
Discussion
In the present work, we have performed large-scale EST
sequencing and analysis in order to generate sufficient
sequence information to study fracture healing at a
genomic level in the sheep for the first time. The results of
our study are of interest not only in the context of fracture
healing and bone development, but will also provide use-
ful information for all fields of research that use the sheep
as a model organism. The ESTs generated in the present
work represent an increase in the number of available
ESTs by a factor of over 4.5, and provide at least partial
sequences for over 5800 sheep genes never before
sequenced. The sequences can be downloaded from the
online supplemental site and are also available in the
GeneNest Sheep database.
Genomic approaches to the sheep have great potential to
accelerate progress in research areas using the sheep as a
model organism. For instance, the first study using an
ovine cDNA microarray prepared from unpublished EST
libraries was very recently published. A number of genes
differentially expressed in sheep resistant and susceptible
to gastrointestinal nematode infection were identified
[16].
Although we now have initial concepts of the molecular
processes involved in fracture healing, many questions
remain to be answered before a comprehensive picture of
the genetic programs involved in fracture healing can
emerge. An in-depth understanding of the genes involved
in fracture healing and the regulatory mechanisms that
control them will be prerequisite for developing optimal
treatments for disturbances of fracture healing and will
have relevance to other disorders such as osteoporosis. At
present, we still do not have a comprehensive list of key
genes and gene products involved in bone development
and fracture healing. In this study, we have performed the
first large-scale EST sequencing project using a model for
fracture healing and have identified numerous differen-
tially regulated genes not previously known to be
involved in fracture healing. EST sequencing gives a nearly
unbiased view of highly expressed sequences in a tissue
(assuming that the process of producing the ESTs does not
introduce a significant amount of bias), and therefore
offers some advantages over candidate gene approaches
and even over microarray-based approaches that may not
cover the entire genome.
In this work, we have generated a profile of postfracture
day 7 and day 10 genetic expression using EST libraries
produced by automated plasmid purification. No normal-
ization procedures were applied to select ESTs for
sequencing. Therefore, we believe that the distribution of
ESTs in these libraries gives a nearly unbiased view of
genetic expression at these stages of fracture healing. InBMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
Page 10 of 20
(page number not for citation purposes)
addition, we generated a third EST library from a pool of
later stages of fracture healing and used RT-PCR to exam-
ine differential expression of 30 of the 39 genes found to
be enriched in the PF7 and PF10 libraries and 48 other
genes (Tables 2 and 3).
Previous genomic approaches to fracture healing have
involved analysis of a rat femur fracture model based
mainly on microarray expression analysis, but different
experimental and statistical approaches were used
[11,17,18]. These studies have collectively identified
Table 3: Supplemental genes investigated by RT-PCR for differential xpression. See Methods for abbreviations and Table 2 for 
explanations.
Gene UniGene EST Ratio RT-PCR Bone/Development
COL1A2 Hs.489142 522:210 (0.51; p = 1.2 × 10-12) */**/** +/+ [60]
ITGB1 Hs.429052 8:21 (0.078; p= 1.5 × 10-8) -/**/** +/+ [78]
COL6A2 Hs.420269 111:56 (0.41; p = 2.8 × 10-5) -/**/** +/+ [79]
TAGLN2 Hs.517168 110:8 (2.8; p = 0.054) -/**/** -/-
CTSS Hs.181301 34:0 (-; p = 0.069) -/**/** -/+ [80]
MORF4L1 Hs.374503 34:0 (-; p = 0.069) -/*/** -/-
GPX3 Hs.386793 36:0 (-; p = 0.073) -/**/** +/+ [17]
Endoglin Hs.76753 32:0 (-; p = 0.087) -/*/** -/+ [30]
RPL9 Hs.412370 32:0 (-; p = 0.087) -/**/** -/+ [81]
CSRP1 Hs.108080 95:7 (2.8; p = 0.089) -/**/** -/+ [29]
RPS4X Hs.446628 31:0 (-; p = 0.11) -/*/** -/-
RPL10a Hs.546269 30:0 (-; p = 0.11) -/**/** -/-
RPL6 Hs.546283 30:0 (-; p = 0.11) -/**/** -/-
PPIB Hs.434937 31:0 (-;p = 0.11) -/**/** +/+ [60]
ANXA2 Hs.511605 158:17 (1.9; p = 0.14) */**/** +/+ [82]
JUNB Hs.25292 27:0 (-;p = 0.15) -/**/** +/+ [83]
RPL17 Hs.374588 27:0 (-;p = 0.15) -/**/** -/-
TPM2 Hs.300772 28:0 (-;p = 0.16) -/**/** -/-
Lumican Hs.406475 114:12 (1.9; p = 0.21) */**/** +/+ [84]
MMP2 Hs.513617 53:20 (0.54; p = 0.21) */**/** +/+ [85]
Perlecan Hs.555874 45:2 (4.6; p = 0.21) */**/** +/+ [86]
RPL41 Hs.381172 0:2 (-;p = 0.21) */**/** -/-
GPX1 Hs.76686 20:0 (-;p = 0.26) */**/** -/-
MMP13 Hs.2936 7:5 (0.29; p = 0.27) **/**/** +/+ [87]
GAPDH Hs.544577 137:17 (1.7; p = 0.36) -/*/** -/-
RARA Hs.535499 9:0 (-;p = 0.37) -/*/* +/+ [88]
ITGA5 Hs.505654 16:0 (-;p = 0.51) */**/** +/+ [89]
BMP1 Hs.1274 16:0 (-;p = 0.51) -/**/** +/+ [90]
GPX7 Hs.43728 16:0 (-;p = 0.51) -/**/** -/-
LRP1 Hs. 162757 16:7 (0.47; p = 0.53) -/**/** -/-
COL4A2 Hs.508716 73:8 (1.9; p = 0.56) */**/** -/-
GPX4 Hs.433951 13:0 (-;p = 0.59) -/**/** -/-
IBSP Hs.518726 8:4 (0.41; p = 0.59) **/**/** +/+ [11]
RPL29 Hs.425125 0:1 (-;p = 0.59) */**/** -/-
S100A4 Hs.81256 13:0 (-;p = 0.59) -/**/** +/+ [91]
ID1 Hs.504609 7:0 (-;p = 0.61) -/*/* +/+ [92]
KDELR2 Hs.520210 10:0 (-;p = 0.76) -/**/** -/-
MMP9 Hs.297413 11:0 (-;p = 0.76) **/*/** +/+ [35]
LRP10 Hs.525232 9:4(0.46; p = 0.83) -/*/* -/-
HDGF Hs.506748 14:5 (0.57; p = 1.0) -/*/* -/+ [32]
COL6A1 Hs.474053 159:29 (1.1; p = 1.0) -/-/* +/+ [79]
CTSD Hs.546248 87:13 (1.4; p = 1.0) **/**/** -/-
CTSK Hs.523594 27:4 (1.4; p = 1.0) */**/** +/+ [93]
ID3 Hs.76884 13:2 (1.3; p = 1.0) -/*/* +/+ [92]
KDELR3 Hs.554798 l:0 (-; p = 1.0) -/**/** -/-
MMP19 Hs. 154057 16:3 (1.1; p = 1.0) -/**/** -/-
TCF4 Hs.200285 5:0 (-;p = 1.0) */*/** +/+ [47]
CST3 Hs.304682 12:2 (1.2; p = 1.0) -/**/** +/+ [37]BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
Page 11 of 20
(page number not for citation purposes)
Estimation of optimal cluster number by gap-stat analysis Figure 6
Estimation of optimal cluster number by gap-stat analysis. The gap statistic for the hierarchical clustering of the genes 
analyzed by RT-PCR. The within-cluster dispersion (an error measure) decreases monotonically as the number of clusters 
increases. If the data do tend to form a certain number of clusters, say k, then the decrease in the within-cluster dispersion will 
flatten markedly thereafter. The gap statistic calculates the value(s) of k at which this happens in order to estimate the optimal 
number of clusters [15]. In the RT-PCR data, two well separated clusters can be identified because of the local maximum at k 
= 2. However, the gap function rises again with a strong increase at k = 4 and k = 6, suggesting the existence of less well sepa-
rated clusters within the main clusters.
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Cluster analysis of RT-PCR expression values Figure 7
Cluster analysis of RT-PCR expression values. A dendogram showing expression profiles of the genes investigated by 
RT-PCR. For each of the 78 genes investigated by RT-PCR, expression values for 10d, 14d, and 42d were normalized to those 
at day 7 and clustered hierarchically by complete linkage (Values for IBSP were normalized to expression at day 10 because 
there was no detectable expression at day 7). The number of clusters was estimated by analysis with the gap-statistic (see Fig. 
6). Six clusters A-F are shown.BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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thousands of genes that are differentially expressed in
fracture healing. The genes were grouped by the authors
into a number of functional classes, which overlap to a
large extent with the classes identified in the present inves-
tigation, including extracellular matrix proteins, ribos-
omal proteins, resorption/remodeling, transcriptional
regulation and signal transduction. However, the specific
genes belonging to the functional classes are often differ-
ent among the three studies cited above as well as in com-
parison to our results. For instance, Hadjiargyrou and
coworkers (2002) identified 20 differentially expressed
ribosomal genes; in the present study, 16 differentially
expressed ribosomal genes were identified. With the
exception of ribosomal protein SA, there is no overlap
between the two lists. This suggests that we are just begin-
ning to identify to the full complement of genes involved
in fracture healing.
Genes differentially expressed in fracture healing
Many of the differentially expressed genes we identified
were previously known to be involved in various biologi-
cal processes involved in bone development or fracture
healing (see Tables 2 and 3 for references), suggesting that
our approach has captured some essential aspects of frac-
ture healing. Additionally, we have demonstrated differ-
ential expression for many genes not previously known to
be involved in fracture healing.
The differentially expressed genes can be divided into sev-
eral different classes, as will be discussed below. Three of
these classes, extracellular matrix proteins, resorption/
remodeling/inflammation, and transcriptional regula-
tion/signal transduction, have been well studied in the
context of fracture healing, and our results have identified
both previously known and novel differentially regulated
genes with these functional roles.
In the following, we describe three other classes with
numerous differentially regulated genes, angiogenesis,
free-radical control, and ribosomal genes. These func-
tional classes have received less attention to date,
although they are known to be involved in the process of
fracture healing. Fracture-related differential expression
had not previously been shown for the great majority of
genes in these classes (cf. Tables 2 and 3). These observa-
tions thus represent starting points for future studies on
the role of processes such as angiogenesis and free-radical
control in fracture healing.
Ribosomal genes
The single largest group of putatively upregulated genes in
our analysis was made up of ribosomal proteins. There are
over 75 ribosomal proteins [19], which are not necessarily
expressed in concert [20]. We found 9 genes coding for
ribosomal proteins to be significantly overexpressed in
our analysis of EST distribution compared to normal
human bone. All of these genes, as well as seven addi-
tional genes coding for ribosomal proteins (Table 3)
showed differential expression in the RT-PCR analysis,
with expression levels peaking at postfracture days 7 and
10 (Fig. 7). We additionally identified four translation fac-
tors as being overexpressed in our EST analysis (Table 2).
RT-PCR for two of these genes confirmed differential
expression. To the best of our knowledge, a specific role in
fracture healing has not been identified for all but two of
these genes to date, although some of them are known to
be differentially expressed in certain developmental proc-
esses (Tables 2 and 3), and a number of other ribosomal
genes are known to be differentially expressed in fracture
healing [11].
Cluster B (Fig. 7) contained 36 genes. Interestingly, 13 of
the 15 ribosomal genes analyzed by RT-PCR, and both of
the translation factors analyzed by RT-PCR were in this
cluster, whose expression levels peaked during the early
phases of fracture healing at days 7 and 10 postfracture,
suggesting that there is an especially high level of protein
synthesis at these stages.
Extracellular matrix proteins
Several matrix proteins were found to be differentially reg-
ulated. The gene with the highest overall expression, Col-
lagen Iα1, is the main protein component of bone, and
the fact that it is one of the most highly upregulated genes
is not surprising. Two other collagens and osteonectin
were also found to be upregulated by EST analysis (Table
2). We investigated these genes and four other collagen
genes and two proteoglycans by RT-PCR and showed dif-
ferential expression for all genes. In general, the expres-
sion of these matrix genes was highest at postfracture day
7 or 10 but was still relatively high at day 14. IBSP is an
osteoblast marker that is a major noncollagenous struc-
tural protein of the bone matrix. IBSP showed an expres-
sion pattern different from that of the other matrix genes,
with significant expression beginning at day 10, peaking
at day 14, and continuing until day 42.
The lysyl-tRNA synthetase KARS has no known involve-
ment in fracture healing. Given the important role of
lysine crosslinks in the biosynthesis of collagen, it is inter-
esting that lysyl-tRNA synthetase was the only tRNA syn-
thetase gene that was overexpressed in our data.
SERPINH1 was also found to be significantly overex-
pressed in the PF7 and PF10 ESTs. It is a molecular chap-
erone involved in the maturation of collagen molecules
[21]. This is presumably important for bone development
because SERPINH1 is localized to regions of type I colla-
gen production in developing murine femurs and tibiae
[22,23].BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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Angiogenesis-related genes
It has long been known that vascular invasion is necessary
for bone differentiation [24], and angiogenesis is a key
process for fracture healing [25]. A number of genes
related to angiogenesis have previously been shown to be
upregulated during bone repair, such as vascular endothe-
lial growth factor [26].
COL3A1 and COL4A1 were shown to be overexpressed in
the PF7 and PF10 ESTs (Table 2). Both of these collagens
have known roles in angiogenesis [27,28].
Six of the eight genes in our dataset with prominent roles
in angiogenesis (CSRP1, COL4A1, COL4A2, Perlecan,
HDGF, Endoglin) were in cluster A. The smooth muscle
marker CSRP1 [29] and the TGFβ-family auxiliary recep-
tor endoglin are required for angiogenesis and heart
development [30,31]. HDGF is a highly expressed vascu-
lar endothelial cell protein [32].
The genes of this cluster show especially strong expression
on day 7 postfracture with lesser amounts of expression
on days 10 and 14, which is not surprising given that new
blood vessel formation is a prerequisite for the formation
of new bone from callus tissue. The other two genes,
COL3A1 and TAGLN2, were in cluster B, which like clus-
ter A is characterized by high early expression (PF7 and
PF10), but shows a stronger drop in expression at the 14
day timepoint.
Resorption, remodeling and inflammation
Several genes that probably play a role in the inflamma-
tory response characteristic of early stages of fracture heal-
ing (FCGRT, Basigin, HLA-A, and CD74) were found to be
overexpressed in the PF7 and PF10 ESTs (Table 2).
Resorption of cartilage and bone mediated by osteoclasts
is an important part of the remodeling processes involved
in new bone formation in fracture healing. The main
enzymes involved are thought to be the cathepsins and
the matrix metalloproteinases (MMPs), which act in a
concerted fashion. Although not all details are clear, our
current understanding of this process suggests that osteo-
clasts create an acidic environment in their resorption
lacunae, which results in dissolution of the mineral, and
then secrete cysteine proteinases that are active at a low
pH, to initiate proteolysis of the proteinaceous bone
matrix. Finally, MMPs exert their activity, once the pH has
increased sufficiently [33]. Our data has demonstrated
differential expression for several enzymes from both
classes.
Interestingly, four of the five genes in RT-PCR cluster E
encode enzymes with roles in osteogenesis (ACP5, CTSK,
MMP9, and MMP13). The first three genes are expressed
by osteoclasts. The expression of genes in this cluster was
minimal at day 7 but peaked at day 10 postfracture, sug-
gesting that these enzymes might be particularly impor-
tant for the processes involved in the bone formation that
becomes visible by day 10.
We showed differential expression for MMP2, MMP9,
MMP13, MMP14, and MMP19. All of these MMPs had
previously known roles in bone development except
MMP19, providing further evidence for the similarity of
bone development and fracture healing. MMP2, MMP9,
and MMP14 are differentially regulated in scarless fetal
wound healing [34] and during osteogenesis [35], which
is interesting because bone is one of the few adult tissues
that can heal without scarring. MMP19 previously had no
known role in skeletal development or fracture healing,
but it is highly expressed in dermal wounds, suggesting a
role in wound repair [36]. The highest expression of
MMP19 was observed in the day 7 and 10 stages.
Cluster F contained only two genes, cystatin C and TPM2.
These genes were the only ones with an expression profile
that peaked at the last time point (42 days postfracture).
Cystatin C (CST3) can inhibit bone resorption and osteo-
clast formation [37]. Osteoclast activity begins early and
increases over the course of fracture healing [38], and one
may speculate that CST3 may be important for regulation
of osteoclasts at this time point.
Control of free radicals
Vascular invasion of ossified cartilage during enchondral
ossification is associated with breakdown of tissue by the
release of lytic enzymes by invading cells such as macro-
phages and endothelial cells. This process is likely to
involve the production of reactive oxygen species (ROS)
[39]. At present, little is known about the mechanisms by
which unwanted tissue damage by ROS is controlled dur-
ing fracture healing. The glutathione peroxidases (GPX)
are enzymes that catalyze the reduction of hydrogen per-
oxide, organic hydroperoxide, and lipid peroxides by
reduced glutathione. They are thus involved in the protec-
tion of cells against oxidative damage. Although none of
the four GPX genes we tested in RT-PCR were individually
statistically significantly overexpressed in the EST analysis,
there were no ESTs for any of these GPX genes in normal
bone and a total of 85 ESTs for the four GPX genes in the
PF7 and PF10 EST libraries. We showed significant differ-
ential expression patterns for each of these genes by RT-
PCR, although they did not show a uniform expression
pattern (Fig. 7).
HMOX1 was also found to be significantly overexpressed
in the PF7 and PF10 EST libraries, as has been previously
described for postfracture day 3 in a rat femur fracture
model [40]. HMOX1 is an inducible heme oxygenase thatBMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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could conceivably be involved in heme catabolism during
resorption of the initial fracture hematoma, although
other roles in development have been postulated for this
gene [41].
Transcription regulation and signal transduction
Two membrane-bound proteins with roles in signal trans-
duction were found to be significantly overexpressed in
the PF7 and PF10 libraries. ITM2C is highly expressed dur-
ing chondro-osteogenic differentiation [42], but its spe-
cific function and its role in fracture healing remain
unknown. The G protein GNAI2 was also found to be
overexpressed, but no clues are available as to its particu-
lar role in fracture healing.
Signal transduction and modification of transcriptional
programs by transcription factors represent important
phenomena in development, and presumably are essen-
tial for fracture healing. Nevertheless, the EST counts for
the transcription factors examined in this study were too
low to reach statistical significance, even though in many
cases ESTs for transcription factors were found only in the
PF7 and PF10 libraries but not in the human normal bone
libraries. For instance, we identified only one EST each for
the transcription factor runx-2 and osterix, which are both
key players in skeletogenesis [43,44].
We performed RT-PCR analysis on a number of transcrip-
tion factors with relatively large numbers of ESTs in our
libraries (Table 3). We were able to demonstrate differen-
tial expression with the highest expression at days 7 and
10, for JunB, which among other roles is a positive regula-
tor controlling primarily osteoblast as well as osteoclast
activity [45]. MORF4L1, which may play a role in mech-
anotransduction [46], and TCF4, which may mediate Wnt
signaling during limb development [47] also showed
highest expression levels in the first two time points. Addi-
tionally, we showed differential expression for NSEP1,
PPIB, and RARA, for which to the best of our knowledge
no previous information about differential expression
during bone development or fracture healing was availa-
ble.
Conclusion
In this work we present approximately 47,000 ESTs from
the domestic sheep. This represents an important resource
to researchers interested in the sheep as a model organism
and greatly expands the number of gene sequences avail-
able for Ovis aries .The sequences are freely available in
GeneNest and the public sequence databases. We have
used the sequences we generated as a tool to investigate
the early stages of fracture healing and have identified
numerous genes that are differentially regulated in early
callus tissues, many of which were not previously known
to have any specific relation to fracture healing or bone
development. These genes will be valuable leads for fur-
ther research into the molecular mechanisms of fracture
healing.
Methods
Fracture model
All animal experiments were carried out according to the
policies and principles established by the Animal Welfare
Act, the NIH Guide for Care and Use of Laboratory Ani-
mals and the national animal welfare guidelines. The
study was approved by the local legal representative
(Landesamt für Arbeitsschutz, Gesundheitsschutz und
technische Sicherheit, Berlin: G 0224/01 and G 0172/04).
The experimental system has been described in detail else-
where [48,49,38]. Briefly, twelve two-year old female
Merino mix sheep with a mean weight of 66 ± 12 kg
underwent a standardized midshaft osteotomy of the
right tibia under general anesthesia. The osteotomy was
distracted to a gap of 3 mm and stabilized with a monol-
ateral external fixator. The fixator consisted of 6 Schanz
screws (5 mm, 3 inserted proximally, 3 inserted distally of
the osteotomy) and 2 steel tubes (10 mm) and was
mounted medially to stabilize the defect.
The osteotomy wound was sutured and the leg, together
with the external fixator, was covered with a tube bandage.
The animals received an analgetic (Finadyne, Essex, Ger-
many) for 3 days postoperatively. Daily pin care involved
cleaning of the insertions of the Schanz screws with
ethacridin lactate (Rivanol, 5%, Chinosol, Germany).
After removal of the fixator under general anesthesia the
callus tissue was removed and sheep were sacrificed. The
tissue was frozen in liquid nitrogen and stored at -80°C
until further use.
Isolation of RNA and library construction
For generation of ESTs, three separate libraries were con-
structed. The first library (PF7) was isolated from four ani-
mals 7 days post-fracture, the second library (PF10) was
isolated from three animals 10 days post-fracture, and the
third library was isolated from a pool of one animal each
at 2 weeks, 3 weeks, and 4.5 weeks post-fracture.
PF7 consisted of 3.6 × 105 clones with an average insert
length of 1.6 kb. PF10 consisted of 3.4 × 105 clones with
an average insert length of 1.4 kb. The pooled library con-
sisted of 4.5 × 106 clones with an average insert size of 1.4
kb. Average insert lengths were determined by screening at
least 300 inserts per library.
For isolation of RNA the tissue was ground in a liquid-
nitrogen-cooled stainless steel mortar. RNA was isolated
with peqGOLD TriFast (peqLab) and subsequently puri-BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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fied with RNeasy Mini columns (Qiagen) followed by
poly(A)-RNA isolation using the polyATtract mRNA Isola-
tion System III (Promega).
For construction of cDNA libraries the CloneMiner cDNA
library construction Kit (Invitrogen) was used according
to the manufacturer's protocol with the following modifi-
cations. All precipitations were carried out using Pellet-
Paint Co-Precipitant (Novagen) instead of glycogen. The
first strand reaction was carried out in five separate reac-
tions with 1 µg poly(A)-RNA each. Four reactions were
precipitated and pooled with the fifth for a single second
strand reaction. Glass fiber filters for radioactive determi-
nation of the cDNA yield were processed separately.
Clones for further analysis were arrayed into 384-well-
microtiter plates by robotic colony picking.
Sequencing and analysis of ESTs
Template DNA for sequencing was prepared by PCR
amplification of cDNA inserts with M13 primers or by
automated plasmid purification. PCR product quality
control was done by 384 well agarose gels, positive prod-
ucts where rearrayed and diluted to appropriate concen-
trations. For plasmid preparation, cultures were grown in
384 deepwell plates containing 200 µl of 2YT Media.
Incubation took 17–18 h at 1100 rpm.
Plasmids were isolated and purified automatically by a
modified alkaline lysis procedure. Quality control of plas-
mids was done by randomly testing eight samples of each
plate on agarose gels. Sequences were determined using
M13 -40 primer, ABI Big Dye Terminator 3 chemistry and
ABI 3730XL capillary sequencer systems (ABI, Weiterstadt,
Germany). All raw sequences were processed by PHRED
[50,51] and screened for vector or Escherichia coli contam-
ination.
Before clustering, sheep EST sequences were subjected to
an extensive quality control procedure. In a first step
sequences were clipped at both ends as long as PHRED
quality values stayed below 20 in a window of size 15 bp.
Secondly, for all sequences (ESTs + mRNAs) putative vec-
tor and repeat sequences were masked. Clustering and
assembly of the clipped sequences was performed using
the GeneNest software tools [12,13].
An Ovis aries EST database
GeneNest is designed to generate and visualize gene indi-
ces based on ESTs and mRNA sequences [12,13]. We have
used the GeneNest software to create a database with
47209 sheep ESTs generated in the current project, as well
as all previously available Ovis aries sequences. The data-
base is available at http://genenest.molgen.mpg.de/cgi-
bin/search_db?db=Oa5.
Accession numbers
All ESTs generated in this project were submitted to
NCBI's GenBank and are available with the accession
numbers [GenBank:DY475559–DY505707] and [Gen-
Bank:DY505714–DY522957].
Identification and annotation of genes
In order to identify and annotate novel and previously
known sheep genes, similarities to known proteins were
identified with a blastx [52] search against the RefSeq pro-
tein database [53] of 28 September, 2005 using default
settings for blastx. Contigs with a best e-value of 10-25 or
lower were assigned a putative identity.
Gene Ontology
For the purpose of Gene Ontology [54] annotation, the
contigs were mapped to mouse mRNAs using blastn with
default settings. Putative identities were assigned using an
e-value threshold of 10-25. Mouse-Genome Informatics
(MGI) annotations [55] were assigned to the sheep
homologs of annotated mouse genes, and GO analysis
was performed using the Ontologizer [56].
Differential expression of early fracture genes
In order to gain insight into the genes that are upregulated
in the early stages of fracture healing in the sheep, we
compared the distribution of ESTs in the PF7 and PF10
sheep libraries against the distribution of ESTs in the Uni-
Gene [6] human bone libraries ID.655 [57] and ID. 1124,
which have a total of 6573 ESTs. Mapping of sheep con-
tigs to human UniGene clusters was performed using
blastn with an e-value cutoff of 10-25 as described above.
We then compared the EST counts for the PF7/PF10 librar-
ies against those in the ID.655/ID.1124 libraries using a
two-tailed Fisher-Exact test. The result of the Fisher-exact
test is a p-value that reflects the probability of observing
the given differences in EST counts in the respective librar-
ies assuming no differential expression [58]. The expres-
sion ratio was calculated based on the total counts of
32032 ESTs in libraries PF7 and PF10 and 6573 ESTs in
UniGene libraries ID.655/ID.1124. A similar test was
applied to compare EST counts in PF7 against those in
PF10. If the p-value of this association test is below a cer-
tain threshold, the gene is considered as putatively differ-
entially expressed. Correction for multiple testing was
performed using a false discovery rate (FDR)-control
method [59]. The FDR represents the expected proportion
of errors among the rejected null hypotheses and is thus a
different kind of procedure from multiple testing correc-
tion procedures such as a Bonferroni correction that con-
trol the family-wise error rate, or the probability that one
or more rejected null hypotheses are falsely rejected. The
Benjamini-Hochberg-adjusted p-values are shown in the
Tables for the EST comparisons.BMC Genomics 2006, 7:172 http://www.biomedcentral.com/1471-2164/7/172
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RT-PCR
RNA was isolated for quantitative reverse-transcriptase
polymerase chain reaction (RT-PCR) from 7-day postfrac-
ture (PF7, n = 4 animals), 10-day postfracture (PF10, n =
3), 14 day (PF14, n = 1) and 42-day (PF42, n = 1) tissue.
PF7 and PF10 were identical to the RNA sources used for
EST library construction, and PF14 was used for the
pooled library. For semi-quantitative RT-PCR measure-
ments, single-stranded cDNA was prepared from the dif-
ferent healing stages using random hexamer primers with
the Taqman Reverse Transcription Reagents Kit (Applied
Biosystems, Forster City, USA). Gene-specific primers
were designed using the Primer Express software (Applied
Biosystems) and quantitative RT-PCR was performed with
SYBR green PCR Master Mix (Applied Biosystems) on an
ABI Prism 7900 HT (Applied Biosystems). The mRNA lev-
els were quantified in triplicate by the standard curve
method normalized to a exogenous green fluorescent pro-
tein (GFP) transcript of which 1 ng was spiked into the
sample per 1 µg of total RNA. See [Additional file 2] for
primer sequences and RT-PCR profiles.
Three measurements were made for each gene at each of
the four time points. Statistical analysis of the RT-PCR
results was performed by a two-sided Student's t test to
compare expression between PF7 and PF10, and one-way
ANOVA was performed to identify differential expression
among the groups PF7, PF10, PF14 or among all four
groups. A Bonferroni correction for multiple testing was
performed.
Clustering and visualization of RT-PCR results
Complete-linkage hierarchical clustering was used to vis-
ualize the results of RT-PCR on the 78 putative fracture-
related genes. For each gene, a vector of four values repre-
senting the four time points was normalized to have zero
mean and unit variance. In order to estimate the optimal
number of clusters, the gap statistic method [15] was
used.
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chrome c oxidase subunit I; CSRP1 = Cysteine and Gly-
cine-Rich Protein 1; CST3 = Cystatin C; CTS = Cathepsin
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